Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GHTF Conference In Brief

This article was originally published in The Gray Sheet

Executive Summary

Permanent GHTF Secretariat?: Steering Committee of the Global Harmonization Task Force has established a working group to "investigate the feasibility of establishing a single, permanent location for the GHTF secretariat," outgoing task force Chair Rita Maclachlan, Therapeutic Goods Administration (Australia), tells attendees at the GHTF ninth annual conference in Singapore May 15. The current practice of rotating the secretariat every 18 months between the five GHTF founding members has become "increasingly difficult" in terms of "efficiency" and maintaining a "coordinate knowledge base," Maclachlan explains. The working group will consider a number of options, including continuing the current arrangement, and has "already identified a number of key issues, including the hosting or location, governance and funding for a permanent secretariat"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel